Literature DB >> 10647595

Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.

E M Scott1, I Gaywood, B B Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10647595      PMCID： PMC1766735          DOI： 10.1136/gut.46.suppl_1.i1

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  72 in total

Review 1.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.

Authors:  S C Manolagas; R L Jilka
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

2.  Bone mineral density in coeliac disease.

Authors:  T Valdimarsson; G Toss; I Ross; O Löfman; M Ström
Journal:  Scand J Gastroenterol       Date:  1994-05       Impact factor: 2.423

3.  Bone mineral affection in asymptomatic adult patients with celiac disease.

Authors:  R Mazure; H Vazquez; D Gonzalez; C Mautalen; S Pedreira; L Boerr; J C Bai
Journal:  Am J Gastroenterol       Date:  1994-12       Impact factor: 10.864

4.  Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss.

Authors:  H Mulder; A Struys
Journal:  Br J Rheumatol       Date:  1994-04

5.  Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

Authors:  K Overgaard; M A Hansen; S B Jensen; C Christiansen
Journal:  BMJ       Date:  1992-09-05

6.  Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.

Authors:  J Adachi; A Cranney; C H Goldsmith; W G Bensen; F Bianchi; A Cividino; G L Craig; E Kaminska; R J Sebaldt; A Papaioannou
Journal:  J Rheumatol       Date:  1994-10       Impact factor: 4.666

7.  Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis.

Authors:  K K Steinberg; S J Smith; S B Thacker; D F Stroup
Journal:  Epidemiology       Date:  1994-07       Impact factor: 4.822

8.  Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.

Authors:  J A Cauley; D G Seeley; K Ensrud; B Ettinger; D Black; S R Cummings
Journal:  Ann Intern Med       Date:  1995-01-01       Impact factor: 25.391

Review 9.  Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis.

Authors:  R Eastell
Journal:  J Intern Med       Date:  1995-05       Impact factor: 8.989

Review 10.  Perspective. How many women have osteoporosis?

Authors:  L J Melton; E A Chrischilles; C Cooper; A W Lane; B L Riggs
Journal:  J Bone Miner Res       Date:  1992-09       Impact factor: 6.741
View more
  57 in total

1.  Osteoporosis and liver disease: additional reasons for coeliac disease screening.

Authors:  M Marignani; S Angeletti; S Morini
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

2.  Is fracture risk increased in patients with coeliac disease?

Authors:  J Compston
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

3.  Review.

Authors:  Mohammad Azam; Maire Buckley; Richard J Farrell
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-04

4.  Current management of corticosteroid-induced osteoporosis: variations in awareness and management.

Authors:  J G Ryan; R K Morgan; P J Lavin; F E Murray; P G O'Connell
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

Review 5.  Recent advances in coeliac disease.

Authors:  D A van Heel; J West
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

6.  Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.

Authors:  Sarah A Bartram; Robert T Peaston; David J Rawlings; David Walshaw; Roger M Francis; Nick P Thompson
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

Review 7.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

8.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

9.  European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 10.  Management of inflammatory bowel disease.

Authors:  M Nayar; J M Rhodes
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.